Loading...

AxoGen, Inc.

0HKD.L•LSE
Healthcare
Medical - Equipment & Services
£12.71
£-0.39(-2.98%)

AxoGen, Inc. (0HKD.L) Stock Overview

Explore AxoGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.8/100

Key Financials

Market Cap616.2M
P/E Ratio-80.34
EPS (TTM)$-0.77
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$9.50
1 Month$11.93
3 Months$20.68
1 Year Target$15.25

0HKD.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AxoGen, Inc. (0HKD.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -80.34 and a market capitalization of 616.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;